Challenges of Convalescent Plasma Infusion Therapy in Middle East Respiratory Coronavirus Infection: A Single Centre Experience
Antiviral Therapy2017Vol. 23(7), pp. 617–622
Citations Over TimeTop 1% of 2017 papers
J.H. Ko, Hyeri Seok, Sun Young Cho, Young Eun Ha, Jin Yang Baek, Kim Ys, Yae‐Jean Kim, Jin Kyeong Park, Chi Ryang Chung, Eun‐Suk Kang, Duck Cho, Marcel A. Müller, Christian Drosten, Cheol‐In Kang, Doo Ryeon Chung, Jae‐Hoon Song, Kyong Ran Peck
Abstract
For effective CP infusion in MERS, donor plasma with a neutralization activity of a PRNT titre ≥1:80 should be used. ELISA IgG could substitute for the neutralization test in resource-limited situations.
Related Papers
- → Discovery of a Novel Coronavirus, China Rattus Coronavirus HKU24, from Norway Rats Supports the Murine Origin of Betacoronavirus 1 and Has Implications for the Ancestor of Betacoronavirus Lineage A(2015)201 cited
- → Current status of treatment for 2019 novel coronavirus pneumonia(2020)2 cited
- → Functional analysis of the MERS-coronavirus spike protein(2014)1 cited
- → Functional analysis of the MERS-coronavirus spike protein(2014)